Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Porcine Serine Peptidase inhibitor Kunitz type 1 (SPINT1) ELISA Kit-Sandwich

Cat. No.EK9F846

Product TypeAnimal Immunoassay Kits

Size

Product Overview

BioVenic Porcine SPINT1 ELISA Kit-Sandwich is designed for the quantitative determination of Porcine serine peptidase inhibitor, Kunitz type 1 (SPINT1) in serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids using a Sandwich ELISA method. For research use only.

Specifications

Assay Type ELISA-Sandwich
Specificity The assay kit is specific for Porcine SPINT1.
Target Species Swine
Species Reactivity Swine
Detection Range 0.2-10 ng/mL
Sensitivity 0.03 ng/mL
Reproducibility Intra-Assay: CV < 10%; Inter-Assay: CV < 10%
Assay Time Around 180 min
Sample Requirement Serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids.

Target Information

Serine peptidase inhibitor Kunitz type 1 is encoded by the SPINT1 gene in pigs. It is significantly reduced in co-existing fetal growth restriction and preeclamptic pregnancies.

Target/Biomarker Porcine SPINT1
Target Synonym serine peptidase inhibitor Kunitz type 1; HAI-1; kunitz-type protease inhibitor 1; hepatocyte growth factor activator inhibitor-1
Gene ID 100157387
UniProt ID A0A8D0IV99

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

  1. Murphy, C. N. et al. Circulating SPINT1 is reduced in a preeclamptic cohort with co-existing fetal growth restriction. Journal of clinical medicine. 2022, 11: 901.
Inquiry Basket